Exchange: NASDAQ·Updated 07:53 PM EST

CTKB News

News
all
press releases
Cytek Biosciences (NASDAQ:CTKB) Sets New 52-Week High - What's Next?
Cytek Biosciences (NASDAQ:CTKB) Reaches New 12-Month High - What's Next...
MarketBeat
Cytek Biosciences (NASDAQ:CTKB) Sets New 52-Week High - What's Next?
Cytek Biosciences (NASDAQ:CTKB) Reaches New 12-Month High - What's Next...
MarketBeat
More News
Cytek Biosciences (NASDAQ:CTKB) Shares Climb 5.4% - Time to Buy...
MarketBeat
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Cytek Biosciences (CTKB) delivered earnings and revenue surprises of +37.50% and +0.62%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Novavax (NVAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Cytek Biosciences (CTKB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Investors need to pay close attention to CTKB stock based on the movements in the options market lately.
Zacks
Cytek Biosciences (CTKB) delivered earnings and revenue surprises of -150.00% and +1.66%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Kyntra Bio (KYNB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Cytek Biosciences (CTKB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks

Advertisement|Remove ads.